4381 |
7MZK |
CD_B |
WCSL 129 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.25 | 10.1016/j.celrep.2021.109822 |
4382 |
7MZK |
FE_A |
WCSL 129 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.25 | 10.1016/j.celrep.2021.109822 |
4383 |
7MZK |
NM_B |
PDI 96 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.25 | 10.1016/j.celrep.2021.109822 |
4384 |
7MZK |
HL_A |
PDI 96 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.25 | 10.1016/j.celrep.2021.109822 |
4385 |
7N0G |
X_A |
Sb45 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.02 | 10.1016/j.jbc.2021.101202 |
4386 |
7N0G |
Y_B |
Sb45 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.02 | 10.1016/j.jbc.2021.101202 |
4387 |
7N0G |
Z_C |
Sb45 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.02 | 10.1016/j.jbc.2021.101202 |
4388 |
7N0H |
X_A |
Sb45 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.34 | 10.1016/j.jbc.2021.101202 |
4389 |
7N0H |
Z_C |
Sb45 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.34 | 10.1016/j.jbc.2021.101202 |
4390 |
7N0I |
I_A |
E2 Nanobody |
SARS-CoV-2 Spike glycoprotein CTD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.2 | 10.3389/fimmu.2021.719037 |
4391 |
7N0I |
J_C |
E2 Nanobody |
SARS-CoV-2 Spike glycoprotein CTD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.2 | 10.3389/fimmu.2021.719037 |
4392 |
7N0I |
K_E |
E2 Nanobody |
SARS-CoV-2 Spike glycoprotein CTD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.2 | 10.3389/fimmu.2021.719037 |
4393 |
7N0I |
L_G |
E2 Nanobody |
SARS-CoV-2 Spike glycoprotein CTD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.2 | 10.3389/fimmu.2021.719037 |
4394 |
7N0R |
C_A |
C2 Nanobody |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
1.42 | 10.3389/fimmu.2021.719037 |
4395 |
7N0R |
D_B |
C2 Nanobody |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
1.42 | 10.3389/fimmu.2021.719037 |
4396 |
7N0U |
HL_C |
REGN5713 Fab |
Major pollen allergen Bet v 1-A |
Mus musculus, Betula pendula |
XRD |
3 | 10.1016/j.jaci.2021.05.038 |
4397 |
7N0V |
HL_C |
REGN5715 Fab |
Major pollen allergen Bet v 1-A |
Mus musculus, Betula pendula |
XRD |
3.71 | 10.1016/j.jaci.2021.05.038 |
4398 |
7N28 |
CD_A |
3BNC117 Fab |
HIV-1 envelope glycoprotein -gp120 |
Human immunodeficiency virus 1, Homo sapiens, Macaca mulatta |
EM |
4.2 | 10.1002/advs.202200063 |
4399 |
7N28 |
JK_F |
3BNC117 Fab |
HIV-1 envelope glycoprotein -gp120 |
Human immunodeficiency virus 1, Homo sapiens, Macaca mulatta |
EM |
4.2 | 10.1002/advs.202200063 |
4400 |
7N28 |
SU_G |
3BNC117 Fab |
HIV-1 envelope glycoprotein -gp120 |
Human immunodeficiency virus 1, Homo sapiens, Macaca mulatta |
EM |
4.2 | 10.1002/advs.202200063 |